We read with great interest a recent paper by Meng et al on the clinical features and prognostic factors of patients with chordoma of the spine. 1 The authors performed a retrospective analysis of 153 patients in a single center. They found that tumor location of C3-L5, dedifferentiated chordoma, preoperative Frankel scores A-C, and total spondylectomy were independent prognostic factors for local relapse-free survival (LRFS), while total en bloc spondylectomy and KPS .80% were favorable factors for overall survival (OS).
We commend the authors for performing the largest study in the literature on spinal chordomas, as the disease is rare and previous published series were limited to a small number of patients. Meng et al argued that having a cohort of patients from a single center reduced the heterogeneity of the data. However, one disadvantage of this approach is that subgroup analysis, with its potential to reveal factors which could have affected LRFS and OS, cannot be performed due to the small sample size. We noted that Meng et al did not find radiotherapy to be an independent prognostic factor for spinal chordomas. This contradicts previous studies that showed the beneficial effect of adjuvant radiotherapy after tumor resection.
2 -4 Therefore, we aimed to further define the role of radiotherapy in patients with spinal chordoma by performing an integrative analysis of 519 cases from the literature with 14 additional cases from our local institution.
We included papers from 1990 to 2015 that presented data on LRFS and OS for individual patients. Studies with incomplete patient information were excluded. We performed univariate and multivariate analysis of prognostic factors on our dataset according to the protocol described by Meng et al. Our cohort comprised 312 men and 179 women; gender was not reported for 42 patients. The mean age was 55 years (median, 57; range, 6 -89). Of these patients, 364 presented with primary chordoma, while 37 presented with chordoma recurrences after initial surgical treatment. Three hundred chordomas were located in the sacrum, with 20 in C1 -L2 and 82 cases in C3 -L5. Out of 498 (96.0%) patients who underwent surgical treatment, 171 (34.3%) had positive margins; 327 (65.7%) had negative margins. The mean follow-up period was 60 months (median, 48 mo; range, 0 -408 mo). Recurrence was detected in 253 (48.4%) patients, and 165 (31.5%) died in the follow-up period. The mean time from surgery to recurrence was 34 months (median, 24; range, 0.1 -204). The mean follow-up for the deceased patients was 61 months (median, 50; range, 0 -408).
We found that the LRFS rate was significantly lower in patients with tumor located in C1 -C2 compared with other tumor sites (P ¼ .03). Other factors that affected LRFS rate on univariate analysis included age, history of previous treatment, pathology (classical vs dedifferentiated type), resection margin, and the use of adjuvant radiotherapy and/or chemotherapy. Only pathology remained significant on multivariate Cox regression analysis. We found the same trend in adjuvant 
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Neuro-Oncology 17(10), 1419 -1422, 2015 radiotherapy as had Meng et al-patients who were treated with postoperative radiotherapy had lower LRFS than those who were not (57.5% vs 39.7%, P , .001). This may be attributed to selection bias, as patients with incomplete resections were more likely to receive radiotherapy than those with complete excisions. Their lower survival rates may be secondary to incomplete resection margin rather than the effect of radiotherapy. In a subgroup analysis of 171 patients with positive margins (Table 1) , we found that those who received radiotherapy had a higher LRFS than those who did not (32.1% vs 12.5%, P ¼ .023). On the multivariate analysis of patients with positive margins, previous treatment history, location in C1 -C2, and tumor size were significantly associated with decreased LRFS. Adjuvant radiotherapy and location in C3 -C5 did not demonstrate significant association with LRFS. However, we acknowledge that this multivariate analysis has a limited sample size (n ¼ 29) and may not have enough power to achieve statistical significance for some factors.
In conclusion, we provided a dataset on spinal chordomas complementary to the paper by Meng et al. Our large sample size enabled us to perform subgroup analysis, which showed that adjuvant radiotherapy may be beneficial in patients with positive surgical margins. Prospective studies in patients with spinal chordoma and positive surgical margins are needed to define the role of postoperative radiotherapy in the management of spinal chordomas.
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